Physician profile
Kent E Morris
NPI 1215128178
$187,149.60
in general payments reported to CMS, 2019-2025
19 companies · $55K in 2025
The $55K reported for 2025 was more than what 96% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,882 · 2021: $12K · 2022: $21K · 2023: $45K · 2024: $38K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $116K · Food and Beverage: $13K · Travel and Lodging: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $115,775.00 |
| Food and Beverage | $12,839.72 |
| Travel and Lodging | $10,274.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $112,462.93 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $27,969.46 | 2019-2025 | General - Therapies, Watchman Access System, Farapulse |
| Medtronic, INC. | $25,976.79 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Medtronic Vascular, INC. | $8,332.18 | 2019-2020 | |
| Biosense Webster, INC. | $3,277.87 | 2019-2025 | Carto 3, Soundstar, Nuvision Ice Catheter |
| E.R. Squibb & Sons, L.L.C. | $2,893.88 | 2019 | |
| Pfizer INC. | $2,817.41 | 2019-2025 | |
| Medical Device Business Services, INC. | $2,062.50 | 2022 | |
| Abbott Laboratories | $376.71 | 2021-2025 | Ensite Precision, Aveir |
| Heartflow, INC. | $267.71 | 2021-2023 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.41 | 2022-2023 | Lifevest |
| Inari Medical, INC. | $147.35 | 2021 | |
| Abiomed | $134.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $65.85 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $65.67 | 2019-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $53.84 | 2019-2024 | |
| Edwards Lifesciences Corporation | $28.45 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.50 | 2022 | |
| Cardiva Medical, INC. | $22.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.